Merlano MC - Search Results

1

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Merlano MC, Paccagnella M, Denaro N, Abbona A, Galizia D, Sangiolo D, Gammaitoni L, Fiorino E, Minei S, Bossi P, Licitra L, Garrone O. Merlano MC, et al. Cancers (Basel). 2023 Nov 2;15(21):5257. doi: 10.3390/cancers15215257. Cancers (Basel). 2023. PMID: 37958430 Free PMC article.

2

Cancer of the oropharynx.

Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2002 Jan;41(1):107-22. doi: 10.1016/s1040-8428(01)00129-9. Crit Rev Oncol Hematol. 2002. PMID: 11796235 Review.

3

Cancer of the larynx.

Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2003 Jul;47(1):65-80. doi: 10.1016/s1040-8428(03)00017-9. Crit Rev Oncol Hematol. 2003. PMID: 12853099 Review.

4

A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer.

Garrone O, Principe E, Occelli M, Mercuri M, Numico G, Granetto C, Di Costanzo G, Rattazzi PD, Merlano M. Garrone O, et al. Anticancer Drugs. 2004 Jan;15(1):23-7. doi: 10.1097/00001813-200401000-00004. Anticancer Drugs. 2004. PMID: 15090739 Clinical Trial.

5

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Numico G, Garrone O, Dongiovanni V, Silvestris N, Colantonio I, Di Costanzo G, Granetto C, Occelli M, Fea E, Heouaine A, Gasco M, Merlano M. Numico G, et al. Cancer. 2005 Mar 1;103(5):994-9. doi: 10.1002/cncr.20893. Cancer. 2005. PMID: 15666321 Free article.

6

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.

Merlano M, Russi EG, Numico G, Colantonio I, Garrone O, Pelissero A, Granetto C, Gasco M, Di Costanzo G, Heouaine A, Vigna Taglianti R, Cipolat M. Merlano M, et al. Radiother Oncol. 2005 May;75(2):193-6. doi: 10.1016/j.radonc.2004.11.007. Epub 2004 Dec 9. Radiother Oncol. 2005. PMID: 16086909 Clinical Trial.

7

Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.

Lo Nigro C, Monteverde M, Riba M, Lattanzio L, Tonissi F, Garrone O, Heouaine A, Gallo F, Ceppi M, Borghi F, Comino A, Merlano M. Lo Nigro C, et al. Int J Oncol. 2010 Nov;37(5):1219-28. doi: 10.3892/ijo_00000773. Int J Oncol. 2010. PMID: 20878069

8

Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.

Denaro N, Russi EG, Adamo V, Colantonio I, Merlano MC. Denaro N, et al. Among authors: merlano mc. Oncology. 2011;81(1):21-9. doi: 10.1159/000330818. Epub 2011 Sep 8. Oncology. 2011. PMID: 21912194 Review.

9

Prediction of anthracycline cardiotoxicity after chemotherapy by biomarkers kinetic analysis.

Garrone O, Crosetto N, Lo Nigro C, Catzeddu T, Vivenza D, Monteverde M, Merlano M, Feola M. Garrone O, et al. Cardiovasc Toxicol. 2012 Jun;12(2):135-42. doi: 10.1007/s12012-011-9149-4. Cardiovasc Toxicol. 2012. PMID: 22189487

10

MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer.

Vivenza D, Gasco M, Monteverde M, Lattanzio L, Syed N, Colantonio I, Denaro N, Natoli G, Comino A, Russi E, Merlano M, Crook T, Lo Nigro C. Vivenza D, et al. Oral Oncol. 2012 Jul;48(7):602-7. doi: 10.1016/j.oraloncology.2012.01.022. Epub 2012 Feb 21. Oral Oncol. 2012. PMID: 22356895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters